Total revenues came in at £6.9 billion ($8.3 billion) – ahead of forecasts – although costs ... from £1.3 billion in the first quarter of 2022, and GSK is expecting the decline to continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback